Table 2. Univariate Cox regression analysis between genes showing SNVs and patients’ OS or clinical covariates previously selected by Log-Rank test in CC patients.
| Covariates | OS | ||
|---|---|---|---|
| HR | 95% CI | p-value | |
| T (TMN) (1-3/4) | 12.33 | 1.28 - 118.8 | 0.029* |
| Stage (I+II+III/IV) | 0.1175 | 0.01 - 0.73 | 0.0221* |
| M (TNM) stage (M0/M1) | 11.7674 | 1.83 - 75.52 | 0.00935* |
| NBN | 14.75 | 2.03 - 106.8 | 0.0004* |
| SMUG1 | 17.754 | 2.42 - 129.8 | 0.0001* |
| ERBB2 | 17.158 | 1.8 - 156.2 | 0.0007* |
| PTPRT | 11.342 | 1.57 - 81.77 | 0.002* |
| EPHB1 | 11.005 | 1.54 - 78.25 | 0.002* |
| ALK | 7.49 | 1.05 - 53.21 | 0.01* |
| PTPRD | 8.0739 | 1.18 - 54.9 | 0.019* |
| AURKB | 8.689 | 1.16 - 64.62 | 0.02* |
| KDR | 6.897 | 0.96 - 49.11 | 0.025* |
| GPR124 | 6.853 | 0.94 - 49.78 | 0.028* |
*p-value ≤ 0.05.